Biogen and Stoke Present New Zorevunersen Data Supporting Phase 3 Dravet Syndrome Study Biogen and Stoke Therapeutics, Inc. (Nasdaq: STOK) today presented new data supporting the design and dosing strategy of the ongoing Phase 3 EMPEROR study of zorevunersen, an…
BeOne, a global oncology company, today announced that the European Commission has approved TEVIMBRA® (tislelizumab) in combination with gemcitabine and cisplatin for the first-line treatment of adult patients with metastatic or recurrent nasopharyngeal carcinoma (NPC) not suitable for curative surgery…
Otsuka Pharmaceutical Launches POCARI SWEAT in India, Strengthening Global Nutraceutical Expansion Otsuka Pharmaceutical Co., Ltd. (Otsuka) has officially launched sales of its popular health drink, POCARI SWEAT, in India as of July. Known for its carefully balanced formula of ions…
Astellas Reports Preliminary U.S. Sales of IZERVAY™ Reach ¥15.9 Billion ($110 Million) in Q1 FY2025 Astellas Pharma , a leading global pharmaceutical company under the leadership of President and CEO Naoki Okamura, today announced preliminary sales figures for its recently…
The Longevity Revolution: Six Biotech Startups Transforming How We Age Armed with cutting-edge biological science, advanced computational tools, and deep-pocketed investors, a new wave of biotech startups is targeting what may be the next frontier in medicine: longevity. With approximately…
Trump Floats 200% Tariffs on Pharma Imports, Offers Industry One-Year Grace Period In a move that could significantly reshape the pharmaceutical supply chain and global drug trade, President Donald Trump announced Tuesday that imported pharmaceutical products could face tariffs of…
Supreme Court Halts Injunction, Allowing RFK Jr.’s HHS Workforce Cuts to Move Forward The U.S. Supreme Court on Tuesday issued a stay that permits the Trump administration to proceed with sweeping federal workforce reductions, including a controversial plan by Health…
AstraZeneca’s Alexion Taps JCR Pharmaceuticals for Gene Therapy Capsids in Deal Worth Up to $825M AstraZeneca’s rare disease unit, Alexion, is deepening its partnership with Japan-based JCR Pharmaceuticals through a new licensing deal that could be worth up to $825…
Nuclidium Secures $99M Series B to Advance Copper-Based Radiopharma Platform Swiss biotech Nuclidium has raised approximately $99 million in a Series B funding round to accelerate the development of its copper-based radiopharmaceutical platform. The round was led by Kurma Growth…
WHO Applauds IMF’s Landmark $700 Million Support to Jordan for Pandemic Preparedness and Response The World Health Organization (WHO) has lauded a groundbreaking decision by the International Monetary Fund (IMF) Executive Board to approve the first-ever Resilience and Sustainability Facility…
Health Secretary Robert F. Kennedy Jr. Endorses Broader RSV Vaccine Use, Following Guidance from Former ACIP Panel Despite ousting the Centers for Disease Control and Prevention’s (CDC) vaccine advisory panel last month, Health and Human Services (HHS) Secretary Robert F.…
Biosynth Unveils Expanded GMP Bioconjugation Facility in Berlin to Advance Next-Generation Therapeutics Biosynth, a global leader in providing essential raw materials and services for the life sciences and diagnostics industries, has officially inaugurated a major expansion of its GMP bioconjugation…